Approval · Notice of Compliance 24329 · 2020
OPTIRAY 240: Notice of Compliance 24329
Issued September 23, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24329
- Date
- September 23, 2020
- Company
- Liebel-Flarsheim Canada IncPointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a mannufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPTIRAY 240 | Not yet assigned | — |
| OPTIRAY 240 ULTRAJECT | Not yet assigned | — |
| OPTIRAY 300 | Not yet assigned | — |
| OPTIRAY 300 ULTRAJECT | Not yet assigned | — |
| OPTIRAY 320 | Not yet assigned | — |
| OPTIRAY 320 ULTRAJECT | Not yet assigned | — |
| OPTIRAY 350 | Not yet assigned | — |
| OPTIRAY 350 ULTRAJECT | Not yet assigned | — |